Product block-copolymer-pcl-peg

Home > products > block-copolymer> pcl-peg

Catalog	name	Description	price
R-C-5145	PCL5000-PEOz2000-SH	Poly(ε-caprolactone)-Poly(2-ethyl-2-oxazoline) is an amphiphilic AB blockcopolymer, PEOz can As apolymer long chain polymer, PEOz has good water solubility, flexibility andbiocompatibility,PEOzcan completely substitute PEG polyethylene glycol as drug carrier material, PCL-PEOz can be used to prepare PHresponsive micelle for drug delivery.	price>
R-C-5164	PCL-PEG350-MAL	Poly(ε-caprolactone)-Polyethyleneglycol-Maleimide is an amphiphilic ABC block copolymer with Maleimide group atthe end of PEG,it is one of the most commonly used biodegradable polymers forself-assemble into polymeric micelles,Maleimide on the micelle surface canconjugate with peptides, antibodies, proteins and others which contain Thiolgroups on the surface.	price>
R-C-5165	PCL-Polyethylene glycol550-MAL	Poly(ε-caprolactone)-Polyethyleneglycol-Maleimide is an amphiphilic ABC block copolymer with Maleimide group atthe end of PEG,it is one of the most commonly used biodegradable polymers forself-assemble into polymeric micelles,Maleimide on the micelle surface canconjugate with peptides, antibodies, proteins and others which contain Thiolgroups on the surface.	price>
R-C-5166	Maleimide-PEG750-PCL	Poly(ε-caprolactone)-Polyethyleneglycol-Maleimide is an amphiphilic ABC block copolymer with Maleimide group atthe end of PEG,it is one of the most commonly used biodegradable polymers forself-assemble into polymeric micelles,Maleimide on the micelle surface canconjugate with peptides, antibodies,proteins and others which contain Thiolgroups on the surface.	price>
R-C-5360	PCL5k-PEI2k-hyd-mPEG5k	The application of PCL hyd mPEG in tissue engineering is very prominent. PCL can degrade and disappear, while mPEG can increase the compatibility of materials with blood and tissues. Therefore, PCL-hyd-mPEG can be used as a natural scaffold material to promote the regeneration and treatment of bone and soft tissues.	price>
R-C-5400	PCL10k-PLL2k	Poly(ε-caprolactone)-poly(L-lysine), also known as PCL-PLL, is a biodegradable and biocompatible polymer blend that has been extensively studied as a drug delivery system. The PCL-PLL polymer blend combines the properties of PCL, a hydrophobic polymer, and PLL, a hydrophilic polymer.	price>
R-C-5427	(L-configuration)TGNYKALHPHNGGGGGHLNILSTLWKYRC-PEG5K-PCL5K	The combination of the peptide sequence,PEG5K,and PCL5K is likely utilized to create a drug delivery system or nanocomplex.The peptide sequence may have specific biological functions,such as targeting certain receptors or facilitating cellular uptake.The PEG and PCL components provide stability,solubility, and controlled release properties,thereby enhancing the potential application of the construct in drug delivery or other biomedical applications.	price>
R-C-5428	PCL5K-PEG5K-CRPPR	The combination of these components in Poly(ε-caprolactone)-Polyethylene glycol-CRPPR allows for the integration of different properties and functionalities.The PCL segment provides biodegradability and controlled release, while the PEG segment improves solubility and biocompatibility.The CRPPR peptide sequence may confer targeting capabilities or enhance cellular interactions.	price>
R-C-5484	PCL-b-PEOz-MAL	Poly(ε-caprolactone)-b-Poly(2-ethyl-2-oxazoline)-Maleimide the polymer chain is composed of alternating blocks of PCL and PEOz. The MAL functional groups are present on the polymer backbone, providing sites for bioconjugation or attachment of therapeutically active molecules.This conjugate can be designed to encapsulate drugs within the PCL core and provide controlled release characteristics.	price>
R-C-5530	PCL3K-TK-PEG5k-Gal	PCL3K-TK-PEG5k-Gal is a complex molecule designed for targeted drug delivery in cancer therapy. It combines a biodegradable polyester (PCL3K) as a structural component, thymidine kinase (TK) as a therapeutic agent, polyethylene glycol (PEG5k) for improved stability and solubility, and galactose (Gal) as a targeting ligand to specifically target cancer cells. This combination enables targeted drug delivery to cancer cells, potentially enhancing the effectiveness of cancer treatment while minimizing side effects on non-cancerous cells.	price>

...